Therapeutic effect of ibrutinib, a selective Bruton’s tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves’ orbitopathyHyun Young Park, Jin Sook Yoon|PLoS ONE|2022Cited by 9